Oman Pharmaceuticals and Healthcare Report Q1 2014:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Join Delanceyplace Sign up to receive a free quote from a non fiction book every weekday. From our sponsors

Oman Pharmaceuticals and Healthcare Report Q1 2014 Nov 20th 2013, 00:00, by vyankatesh BMI View: Developments this quarter showcase strong relations between Oman and India. As one of the main destinations of medical tourism, India will continue to benefit from Oman’s increasingly burdened public healthcare system. Similarly, strong growth prospects in both the pharmaceutical and healthcare industries will provide Indian companies with a healthy return on investment. Headline Expenditure Projections ? Pharmaceuticals: OMR160mn (US$415mn) in 2012 to OMR175mn (US$461mn) in 2013; 9.7% in local currency terms and +11.1% in US dollar terms. Forecast broadly in line with Q413. ? Healthcare: OMR724mn (US$1.88bn) in 2012 to OMR799mn (US$2.05bn) in 2013; +7.6% in local currency … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131641. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/oman-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions